BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31085008)

  • 21. WIF-1 and Ihh Expression and Clinical Significance in Patients With Lung Squamous Cell Carcinoma and Adenocarcinoma.
    Zhang Y; Hu C
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):454-461. PubMed ID: 27801732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis.
    Xu N; Jia D; Chen W; Wang H; Liu F; Ge H; Zhu X; Song Y; Zhang X; Zhang D; Ge D; Bai C
    PLoS One; 2013; 8(3):e59412. PubMed ID: 23536876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma.
    Song BN; Chu IS
    Exp Mol Med; 2018 Jan; 50(1):e418. PubMed ID: 29303511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of FOXM1 Is a Potential Prognostic Marker in Male Breast Cancer.
    Abdeljaoued S; Bettaieb I; Nasri M; Adouni O; Goucha A; El Amine O; Boussen H; Rahal K; Gamoudi A
    Oncol Res Treat; 2017; 40(4):167-172. PubMed ID: 28376490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL.
    Wei P; Zhang N; Wang Y; Li D; Wang L; Sun X; Shen C; Yang Y; Zhou X; Du X
    Int J Biol Sci; 2015; 11(2):186-98. PubMed ID: 25561901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
    Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
    Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel circular RNA, circXPO1, promotes lung adenocarcinoma progression by interacting with IGF2BP1.
    Huang Q; Guo H; Wang S; Ma Y; Chen H; Li H; Li J; Li X; Yang F; Qiu M; Zhao S; Wang J
    Cell Death Dis; 2020 Dec; 11(12):1031. PubMed ID: 33268793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance.
    Yang DK; Son CH; Lee SK; Choi PJ; Lee KE; Roh MS
    Hum Pathol; 2009 Apr; 40(4):464-70. PubMed ID: 19121844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of FoxM1 and BCRP in invasive breast carcinoma of no special type and its prognosis significance].
    Liu Y; Liu YP; Liu JY; Yang HC; Wang ZD
    Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):30-33. PubMed ID: 28072973
    [No Abstract]   [Full Text] [Related]  

  • 31. Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer.
    Abdeljaoued S; Bettaieb L; Nasri M; Adouni O; Goucha A; Bouzaiene H; Boussen H; Rahal K; Gamoudi A
    Breast Dis; 2018; 37(3):109-114. PubMed ID: 29504520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma.
    Xiao Z; Jia Y; Jiang W; Wang Z; Zhang Z; Gao Y
    Thorac Cancer; 2018 Aug; 9(8):997-1004. PubMed ID: 29877046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.
    Ito T; Kohashi K; Yamada Y; Maekawa A; Kuda M; Furue M; Oda Y
    Histopathology; 2016 Jul; 69(1):63-71. PubMed ID: 26619071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients.
    Liu S; Li Y; Qi W; Zhao Y; Huang A; Sheng W; Lei B; Lin P; Zhu H; Li W; Shen H
    Diagn Pathol; 2014 Mar; 9():69. PubMed ID: 24661909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.
    Wang Y; Zhang W; Wen L; Yang H; Wen M; Yun Y; Zhao L; Zhu X; Tian L; Luo E; Li Y; Liu W; Wen N
    Oncotarget; 2016 Sep; 7(37):59245-59259. PubMed ID: 27494877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
    Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
    Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1.
    Jiao X; Yu W; Qian J; Chen Y; Wei P; Fang W; Yu G
    BMC Cancer; 2018 May; 18(1):570. PubMed ID: 29776401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung Adenocarcinoma.
    Hashinokuchi A; Matsubara T; Ono Y; Shunichi S; Matsudo K; Nagano T; Kinoshita F; Akamine T; Kohno M; Takenaka T; Oda Y; Yoshizumi T
    Ann Surg Oncol; 2024 Jul; 31(7):4822-4829. PubMed ID: 38461192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.
    Yan J; Wei Q; Jian W; Qiu B; Wen J; Liu J; Fu B; Zhou X; Zhao T
    Lung; 2016 Feb; 194(1):137-46. PubMed ID: 26608347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
    Pan GF; Zhou XF; Zhao JP
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.